glp 1 heart rate Retatrutide rate: what the clinical data actually shows Possible mechanisms of action of

V., & Elisaf, M

[DOI] [PMC free article] [PubMed] [Google Scholar] 101.Dicker D., Sagy Y.W., Ramot N., Battat E., Greenland P., Arbel R., Lavie G., Reges O

In a clinical trial involving individuals with established cardiovascular disease, retatrutide reduced the risk of major adverse cardiovascular events, such as heart attacks, strokes, and cardiovascular death

Evaluating Biometric Trend Drivers: How to reflect medical breakthroughs and other drivers in forward-looking assumptions explores the practicalities of how to maintain an up-to-date view on emerging drivers such as AOMs and provides a framework for incorporating insured impacts into insured improvement bases